Elnur Gasimov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elnur Gasimov has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Aitaj Badalova
Department of Pathophysiology, Azerbaijan Medical University, Baku, Azerbaijan, Azerbaijan
2 shared publications - E. K. Aghayev
Azerbaijan Medical University
2 shared publications - Emilya Balayeva
Azerbaijan Medical University, Baku, Azerbaijan, Azerbaijan
2 shared publications - Kubra Aliyeva
Azerbaijan Medical University, Baku, Azerbaijan, Azerbaijan
2 shared publications - Tahir Suleymanov
Department of Pharmaceutical Chemistry, Azerbaijan Medical University, Baku AZ1022, Azerbaijan
2 shared publications - Abolghasem Jouyban
Pharmaceutical Analysis Research Center, Pharmaceutical Sciences Institute, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by Scientific Society Anatomists, Histologists, and Embryologists, Ukraine in World of Medicine and Biology
- Vol. 22 (97) , 139-145
ДІАГНОСТИКА ТА РЕЗУЛЬТАТИ ЛІКУВАННЯ ГОСТРОГО МЕДІАСТИНІТУ ПРИ ТРАВМАХ ГРУДНОГО ВІДДІЛУ СТРАВОХОДУ
До ретроспективного дослідження було включено 47 послідовних пацієнтів (20 чоловіків і 27 жінок) віком від 32 до 59 років, які проходили лікування з приводу гострого медіастиніту, вторинного щодо відкритих і закритих ушкоджень грудного відділу стравоходу, на кафедрі загальної хірургії Азербайджанського медичного університету (Баку, Азербайджан) у період з січня 2000 року по грудень 2025 року. Причинами ушкодження стравоходу були перфорація чужорідними тілами (n = 19), ятрогенні ушкодження (n = 15), спонтанний розрив стравоходу (n=8), колото-різані та вогнепальні поранення (n=3), а також поєднане ушкодження трахеї та стравоходу при тупій травмі грудної клітки (n=2). Діагностика ґрунтувалася на клінічному обстеженні, рентгеноконтрастному дослідженні стравоходу, комп’ютерній томографії та езофагоскопії. Хірургічне лікування включало дренування середостіння та плевральних порожнин, торакотомію, ушивання дефекту стравоходу за наявності технічних можливостей та комплексну інтенсивну післяопераційну терапію. Найбільш інформативними методами діагностики для виявлення перфорації стравоходу та оцінки поширеності запального процесу в середостінні виявилися комп’ютерна томографія та контрастне дослідження стравоходу. Отримані результати підтверджують важливість ранньої діагностики, своєчасного хірургічного втручання та комплексного післяопераційного лікування як основних складових успішного лікування гострого медіастиніту, що розвинувся внаслідок ушкодження грудного відділу стравоходу.
- 30 September 2026
- Published by Scientific Society Anatomists, Histologists, and Embryologists, Ukraine in World of Medicine and Biology
- Vol. 22 (97) , 139-145
Open AccessДІАГНОСТИКА ТА РЕЗУЛЬТАТИ ЛІКУВАННЯ ГОСТРОГО МЕДІАСТИНІТУ ПРИ ТРАВМАХ ГРУДНОГО ВІДДІЛУ СТРАВОХОДУ
До ретроспективного дослідження було включено 47 послідовних пацієнтів (20 чоловіків і 27 жінок) віком від 32 до 59 років, які проходили лікування з приводу гострого медіастиніту, вторинного щодо відкритих і закритих ушкоджень грудного відділу стравоходу, на кафедрі загальної хірургії Азербайджанського медичного університету (Баку, Азербайджан) у період з січня 2000 року по грудень 2025 року. Причинами ушкодження стравоходу були перфорація чужорідними тілами (n = 19), ятрогенні ушкодження (n = 15), спонтанний розрив стравоходу (n=8), колото-різані та вогнепальні поранення (n=3), а також поєднане ушкодження трахеї та стравоходу при тупій травмі грудної клітки (n=2). Діагностика ґрунтувалася на клінічному обстеженні, рентгеноконтрастному дослідженні стравоходу, комп’ютерній томографії та езофагоскопії. Хірургічне лікування включало дренування середостіння та плевральних порожнин, торакотомію, ушивання дефекту стравоходу за наявності технічних можливостей та комплексну інтенсивну післяопераційну терапію. Найбільш інформативними методами діагностики для виявлення перфорації стравоходу та оцінки поширеності запального процесу в середостінні виявилися комп’ютерна томографія та контрастне дослідження стравоходу. Отримані результати підтверджують важливість ранньої діагностики, своєчасного хірургічного втручання та комплексного післяопераційного лікування як основних складових успішного лікування гострого медіастиніту, що розвинувся внаслідок ушкодження грудного відділу стравоходу.
- Open Access
- 2 July 2026
- Published by MDPI AG in Preprints.org
Development and Validation of an HPLC-UV Method for the Determination of Levofloxacin from a Prolonged–Release Mesh Implant in Rat Blood
Levofloxacin (LVX) is a broad-spectrum antibiotic whose systemic administration can be limited by adverse effects and suboptimal drug levels at infection sites. Implantable drug-loaded meshes offer a promising strategy for localized, prolonged delivery. This study developed and validated a simple, rapid, and reliable high-performance liquid chromatography with ultraviolet detection (HPLC-UV) method for quantifying LVX in rat blood to support the preclinical evaluation of a prolonged-release LVX-loaded polypropylene mesh. The method utilized a Zorbax SB-C18 column with an isocratic mobile phase of acetonitrile:0.1% orthophosphoric acid (80:20, v/v) at a flow rate of 1.4 mL/min, with detection at 296 nm. Validation according to ICH Q2(R2) guidelines demonstrated excellent linearity (R² = 0.999) over 1–8 µg/mL, accuracy (mean recovery 99.68%), and precision (intra- and inter-day CV < 0.3%). The limits of detection and quantification were 0.3 µg/mL and 1.0 µg/mL, respectively. The validated method was successfully applied to quantify LVX in rat plasma samples collected over 10 days post-implantation, confirming its suitability for pharmacokinetic studies of implant-based antibiotic delivery systems. This method provides a practical and robust analytical tool for routine preclinical assessment of LVX release and systemic exposure from localized delivery devices.
- 2 July 2026
- Published by MDPI AG in Preprints.org
Open AccessDevelopment and Validation of an HPLC-UV Method for the Determination of Levofloxacin from a Prolonged–Release Mesh Implant in Rat Blood
Levofloxacin (LVX) is a broad-spectrum antibiotic whose systemic administration can be limited by adverse effects and suboptimal drug levels at infection sites. Implantable drug-loaded meshes offer a promising strategy for localized, prolonged delivery. This study developed and validated a simple, rapid, and reliable high-performance liquid chromatography with ultraviolet detection (HPLC-UV) method for quantifying LVX in rat blood to support the preclinical evaluation of a prolonged-release LVX-loaded polypropylene mesh. The method utilized a Zorbax SB-C18 column with an isocratic mobile phase of acetonitrile:0.1% orthophosphoric acid (80:20, v/v) at a flow rate of 1.4 mL/min, with detection at 296 nm. Validation according to ICH Q2(R2) guidelines demonstrated excellent linearity (R² = 0.999) over 1–8 µg/mL, accuracy (mean recovery 99.68%), and precision (intra- and inter-day CV < 0.3%). The limits of detection and quantification were 0.3 µg/mL and 1.0 µg/mL, respectively. The validated method was successfully applied to quantify LVX in rat plasma samples collected over 10 days post-implantation, confirming its suitability for pharmacokinetic studies of implant-based antibiotic delivery systems. This method provides a practical and robust analytical tool for routine preclinical assessment of LVX release and systemic exposure from localized delivery devices.
- Open Access
Development and Validation of Spectrophotometric Method for Determination of Levofloxacin in Rat Plasma
A simple, rapid, and cost-effective UV–Vis spectrophotometric method was developed and validated for the determination of levofloxacin in rat plasma to support the evaluation of a novel antimicrobial mesh implant containing levofloxacin, chitosan, gelatin, tinctura propolis, citric, acid and glycerin. Plasma samples were treated with 0.1 M HCl, and absorbance was measured at 290 nm. The method was validated according to FDA and ICH guidelines, including assessments of linearity, sensitivity, accuracy, precision, and specificity. The calibration curve was linear over the concentration range of 2.5–12.5 μg/mL (R2 = 0.999, p < 0.001). The limit of detection and limit of quantification were 0.21 μg/mL and 0.62 μg/mL, respectively. Intra- and inter-day precision showed low relative standard deviation values (0.2% and 0.25%), while recovery ranged from 94.8% to 96.4%, confirming acceptable accuracy. No significant interference from plasma matrix components was observed. Compared with chromatographic techniques, the proposed method provides an accessible alternative for routine bioanalysis and therapeutic monitoring. The validated assay is suitable for assessing prolonged levofloxacin release from implantable drug delivery systems in preclinical studies.
Open AccessDevelopment and Validation of Spectrophotometric Method for Determination of Levofloxacin in Rat Plasma
A simple, rapid, and cost-effective UV–Vis spectrophotometric method was developed and validated for the determination of levofloxacin in rat plasma to support the evaluation of a novel antimicrobial mesh implant containing levofloxacin, chitosan, gelatin, tinctura propolis, citric, acid and glycerin. Plasma samples were treated with 0.1 M HCl, and absorbance was measured at 290 nm. The method was validated according to FDA and ICH guidelines, including assessments of linearity, sensitivity, accuracy, precision, and specificity. The calibration curve was linear over the concentration range of 2.5–12.5 μg/mL (R2 = 0.999, p < 0.001). The limit of detection and limit of quantification were 0.21 μg/mL and 0.62 μg/mL, respectively. Intra- and inter-day precision showed low relative standard deviation values (0.2% and 0.25%), while recovery ranged from 94.8% to 96.4%, confirming acceptable accuracy. No significant interference from plasma matrix components was observed. Compared with chromatographic techniques, the proposed method provides an accessible alternative for routine bioanalysis and therapeutic monitoring. The validated assay is suitable for assessing prolonged levofloxacin release from implantable drug delivery systems in preclinical studies.
- Open Access
- 7 July 2019
- Published by Liga-Inform, Ltd. in Klinicheskaia khirurgiia
- Vol. 86 (7) , 9-12
Efficacy of application of a human placenta hydrolysate in prophylaxis of the intestinal anastomoses sutures insufficiency
Objective. Studying of impact of a human placenta hydrolysate on regeneration of intestinal anastomosis and prophylaxis of their sutures insufficiency. Materials and methods. Experimental investigations were conducted on two groups of rabbits. In every group a simulation model of an acute strangulation ileus was created. In a one day a relaparotomy, resection of necrotized intestinal segments with anastomosing in a “side-to-side” fashion were done in rabbits of both groups. After the operation the control group rabbits have obtained a standard treatment, while in the main group the rabbits together with a standard treatment have obtained a human placenta hydrolysate preparation «Laennec». On the days 3, 5, 7 and 15th the according intestinal segments were probed for morpho-histochemical investigations. Clinical investigations were conducted in 122 patients, consisting of resection of intestinal segments with formation of anastomoses. The control group consisted of 60 patients, and the main one – in 62. The data of the control group were studied retrospectively. In the main group the patients, together with a standard treatment, a human placenta hydrolysate in a form of preparation “Laennec” was applied for prophylaxis of insufficiency of the intestinal anastomoses sutures. Results. Basing on experimental results it may be stressed, that application of preparation «Laennec» strengthens regeneration and angiogenesis in zone of anastomosis, because in animals of the main group, comparing with a control one, high mitotic index, good angiogenesis and the motor-evacuation function integrity were noted. In clinical practice the anastomotic sutures insufficiency in the control group have occurred in 13.3% of observations, and in the main group – in 1.6% of observations. Conclusion. Application of the human placenta hydrolysate for prophylaxis of the sutures insufficiency in intestinal anastomoses is affordable due to successive clinical and experimental data obtained.
- 7 July 2019
- Published by Liga-Inform, Ltd. in Klinicheskaia khirurgiia
- Vol. 86 (7) , 9-12
Open AccessEfficacy of application of a human placenta hydrolysate in prophylaxis of the intestinal anastomoses sutures insufficiency
Objective. Studying of impact of a human placenta hydrolysate on regeneration of intestinal anastomosis and prophylaxis of their sutures insufficiency. Materials and methods. Experimental investigations were conducted on two groups of rabbits. In every group a simulation model of an acute strangulation ileus was created. In a one day a relaparotomy, resection of necrotized intestinal segments with anastomosing in a “side-to-side” fashion were done in rabbits of both groups. After the operation the control group rabbits have obtained a standard treatment, while in the main group the rabbits together with a standard treatment have obtained a human placenta hydrolysate preparation «Laennec». On the days 3, 5, 7 and 15th the according intestinal segments were probed for morpho-histochemical investigations. Clinical investigations were conducted in 122 patients, consisting of resection of intestinal segments with formation of anastomoses. The control group consisted of 60 patients, and the main one – in 62. The data of the control group were studied retrospectively. In the main group the patients, together with a standard treatment, a human placenta hydrolysate in a form of preparation “Laennec” was applied for prophylaxis of insufficiency of the intestinal anastomoses sutures. Results. Basing on experimental results it may be stressed, that application of preparation «Laennec» strengthens regeneration and angiogenesis in zone of anastomosis, because in animals of the main group, comparing with a control one, high mitotic index, good angiogenesis and the motor-evacuation function integrity were noted. In clinical practice the anastomotic sutures insufficiency in the control group have occurred in 13.3% of observations, and in the main group – in 1.6% of observations. Conclusion. Application of the human placenta hydrolysate for prophylaxis of the sutures insufficiency in intestinal anastomoses is affordable due to successive clinical and experimental data obtained.